Drug intelligence / Profile preview

AUBE00

Development stage
Phase 1
Lead developer
Chugai Pharmaceutical
Modality
Small Molecules, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Oral
01

Overview

AUBE00 is an **investigational drug** being developed by **Chugai Pharmaceutical** for the treatment of **solid tumors**. It is currently in **Phase 1 clinical trials** for patients with advanced solid malignancies. The available data indicate it is being studied as a **first-in-human therapy** to evaluate its safety, pharmacokinetics, and preliminary activity. The drug is administered orally. While the **precise modality and mechanism of action** have not been publicly disclosed, AUBE00 is mentioned among investigational antibody-drug conjugates (ADCs) in pipeline summaries, suggesting it may be an ADC or related modality. Further details on its molecular target or payload have not been released[1][2][3][4][6][7][8][9].

Other names
AUBE00AUBE-00AUBE 00

Beyond the preview

Go deeper on AUBE00.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AUBE00.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call